跳至主要内容
临床试验/jRCT1031250780
jRCT1031250780招募中不适用

A Prospective Exploratory Clinical Study Evaluating the Efficacy and Safety of the INOFlo System in Cases of Cardiogenic Shock Under Impella Support

未提供0 个研究点目标入组 16 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • (1) Individuals with cardiogenic shock under hemodynamic support with Impella.
  • (2) Individuals within 5 days of initiating Impella support and not yet introduced to nitric oxide therapy.
  • (3) Individuals with a pulmonary artery catheter inserted.
  • (4) Individuals with pulmonary hypertension (mean pulmonary artery pressure >= 21 mmHg and PVR >= 2 Wood units).
  • (5) Age: Individuals aged >= 18 years at the time of informed consent.
  • (6) Gender: Not specified.
  • (7) Individuals who have provided voluntary written informed consent (by themselves or a legal representative) after receiving sufficient explanation and achieving full understanding for participation in this study

排除标准

  • (1) Individuals in whom ECMO or IMPELLA does not function stably due to factors other than right ventricular afterload.
  • (2) Individuals with persistent severe hypotension with mean arterial pressure < 50 mmHg even under ECPELLA support.
  • (3) Individuals with severe hepatic impairment, renal impairment, or cardiovascular disease (determined with reference to Grade 3 of JCOG CTCAE version 5.0).
  • (4) Individuals undergoing or requiring prohibited concomitant therapies.
  • (5) Others judged inappropriate for participation in this study by the investigator or sub-investigator.

研究者

发起方
未提供

相似试验